Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet.

Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next.

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfill their aspirations. Join Kite and help create more tomorrows.

Job Description

We are seeking a Director, Global Value & Access Strategy (GVAS), Cell-therapy Autoimmune. This role reports to the Senior Director, GVA Lead, Lymphoma, Autoimmune and Solid Tumors/Pipeline.

This role will be office-based/hybrid (3 days onsite) in El Segundo or Thousand Oaks or Foster City, CA.

In this position, you will be a critical Global Value & Access partner for Kite's growing autoimmune cell therapy portfolio. You will lead the development and execution of global market access strategies to support early and late-stage development programs, while preparing for future launches of transformative cell therapies across autoimmune diseases.

You will work closely with Global Clinical Development, Medical Affairs, HEOR/RWE, Commercial, Regulatory Affairs and regional Access teams to ensure payer perspectives are incorporated into development decisions and launch planning. You will play a key role in shaping evidence generation strategies that support differentiated value propositions, reimbursement, and patient access across major global markets.

Key Responsibilities

Strategic Market Access Leadership

• Serve as the Global Market Access representative for assigned autoimmune programs and contribute to cross-functional conversations.

• In the Value Access Sub-Team, you will be leading and partnering with the Global and Regional functions of Value Access, HEOR/RWE and commercial to ensure efficient integration of Access input into the Portfolio Strategy.

• Lead the development of global value and access strategies across the product lifecycle, from early development through launch and lifecycle management.

• Ensure payer, HTA, and health system perspectives are reflected in development, evidence generation, pricing, and commercialization strategies.

• Partner with regional and country access teams to develop integrated global-to-local reimbursement strategies.

Asset Development and Evidence Generation

• Analyze market access trends, evolving reimbursement requirements, competitive dynamics, and health system considerations across major markets including the US, EU5, Canada, Australia, and Japan.

• Provide market access input into target product profiles, clinical development plans, endpoint selection, comparator strategy, study design, and evidence generation plans.

• Advise development teams on evidence requirements needed to support future reimbursement, pricing, and formulary access decisions.

• Ensure access-relevant considerations are incorporated into development milestones and governance decisions.

Value Demonstration and HEOR Partnership

• Partner with Clinical, HEOR, RWE and Medical Affairs to develop and execute early payer engagement and HTA scientific advice strategies across multiple autoimmune indications, ensuring payer perspectives are incorporated into evidence generation and development plans.

• Provide strategic leadership on US market access dynamics across autoimmune indications, including payer formulary management, utilization management (e.g., step edits and prior authorization), and rebate contracting strategies, ensuring these considerations are proactively incorporated into development, evidence generation, pricing, and launch planning.

• Lead cross-functional assessment of payer, HTA, and health system evidence requirements across key global markets, translating insights into actionable recommendations for clinical development programs.

• Assess the access implications of development opportunities across autoimmune indications and advise governance teams on the likelihood of achieving favorable pricing, reimbursement, and patient access outcomes.

• Partner with HEOR, RWE, Medical Affairs, and Commercial teams to develop compelling value propositions and evidence packages.

• Advise on the development of economic models, burden-of-illness studies, indirect treatment comparisons, and other payer-focused evidence.

Cross-Functional Leadership

• Act as the market access lead within cross-functional teams, ensuring alignment across Development, Medical Affairs, Commercial, Regulatory Affairs, Pricing, and HEOR.

…